Correspondence 0001193125-23-073850 from Cullinan Therapeutics, Inc. (CGEM) (CIK 0001789972) (CGEM)
Cullinan Therapeutics, Inc. (CGEM) (CIK 0001789972)
Date: March 17, 2023 · CIK: 0001789972 · Accession: 0001193125-23-073850
AI Filing Summary & Sentiment
File numbers found in text: 333-270384
Letter
CULLINAN ONCOLOGY, INC.
One Main Street, Suite 1350
Cambridge, MA 02142
March 17, 2023
VIA EDGAR
Securities and Exchange Commission
Division of Corporate Finance
100 F Street, N.E.
Washington, D.C. 20549
Attention: Jimmy McNamara
Re: Cullinan Oncology, Inc.
Registration Statement on Form S-3 (File No. 333-270384)
Ladies and Gentlemen:
We hereby withdraw Cullinan Oncology Inc’s request for acceleration of effectiveness of the Registration Statement on Form S-3 (File No. 333-270384) made on March 9, 2023.
Please direct any questions regarding this filing to Tom Danielski at (617) 235-4961.
CULLINAN ONCOLOGY, INC.
By:
/s/ Jeffrey Trigilio
Name:
Jeffrey Trigilio
Title:
Chief Financial Officer
Show Raw Text
CORRESP 1 filename1.htm CORRESP CULLINAN ONCOLOGY, INC. One Main Street, Suite 1350 Cambridge, MA 02142 March 17, 2023 VIA EDGAR Securities and Exchange Commission Division of Corporate Finance 100 F Street, N.E. Washington, D.C. 20549 Attention: Jimmy McNamara Re: Cullinan Oncology, Inc. Registration Statement on Form S-3 (File No. 333-270384) Ladies and Gentlemen: We hereby withdraw Cullinan Oncology Inc’s request for acceleration of effectiveness of the Registration Statement on Form S-3 (File No. 333-270384) made on March 9, 2023. Please direct any questions regarding this filing to Tom Danielski at (617) 235-4961. CULLINAN ONCOLOGY, INC. By: /s/ Jeffrey Trigilio Name: Jeffrey Trigilio Title: Chief Financial Officer